Profilo
Zhanna Jumadilova is currently the Chief Clinical Development Officer at Clarus Therapeutics Holdings, Inc. Prior to this, he was the Vice President-Clinical Development at Insmed, Inc. from 2019 to 2021.
He also worked at AstraZeneca, Inc. as a General Manager.
Jumadilova holds an MBA from Joseph M.
Katz Graduate School of Business and a doctorate from Kazakh National Medical University.
Posizioni attive di Zhanna Jumadilova
| Società | Posizione | Inizio |
|---|---|---|
| CLARUS THERAPEUTICS HOLDINGS, INC. | Corporate Officer/Principal | 17/01/2022 |
Precedenti posizioni note di Zhanna Jumadilova
| Società | Posizione | Fine |
|---|---|---|
| INSMED INCORPORATED | Corporate Officer/Principal | 01/10/2021 |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Corporate Officer/Principal | - |
Formazione di Zhanna Jumadilova
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Insmed, Inc.
Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
Joseph M. Katz Graduate School of Business
Joseph M. Katz Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kazakh National Medical University
Kazakh National Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clarus Therapeutics Holdings, Inc.
Clarus Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops oral T-replacement therapies | Health Technology |
















